Dose reduction, suspension, or discontinuation of chemotherapy due to CIPN
CIPN
The incidences of chemotherapy dose reduction, suspension, and discontinuation due to all causes were 7.7%, 23.1%, and 34.6%, and those due to CIPN were 5.8%, 1.9%, and 3.8%, respectively (Table Incidence of dose reduction, suspension, or discontinuation of chemotherapy

